• 

  More pharma firms should be allowed to make Covid vaccine: Gadkari

  India | May 19, 2021 12:31 IST

  There are two vaccine makers in the country currently -- Bharat Biotech and Serum Institute of India -- which are manufacturing Covaxin and Covishield, respectively. Only three vaccines have so far been approved to be sold in India --- Covaxin, Coveshield and Sputnik V.

• 

  'Never exported vaccines at the cost of people in India': Adar Poonawalla

  India | May 19, 2021 0:05 IST

  Serum Institute of India (SII) CEO Adar Poonawalla said that vaccination in a large populous country such as India won't be possible in 2-3 months.

• 

  WHO reminds Serum Institute of its COVAX commitments amidst devastating COVID-19 outbreak

  Business | May 18, 2021 11:10 IST

  WHO chief Tedros Adhanom Ghebreyesus has said that once the devastating COVID-19 outbreak in India recedes, the Serum Institute of India will need to “get back on track and catch up” on its delivery commitments to COVAX, the global initiative to supply coronavirus vaccines to nations around the world.

• 

  Covishield monthly production to touch 10 crore by August, Covaxin 7.8 crore

  India | May 13, 2021 7:55 IST

  Serum Institute and Bharat Biotech have submitted to the Centre that they can ramp up production of Covishield and Covaxin to 10 crore and 7.8 crore doses, respectively, by August.

• 

  Working closely with govt, got all kinds of support: Adar Poonawalla on vaccine production

  India | May 03, 2021 17:02 IST

  Serum Institute of India (SII) CEO Adar Poonawalla has issued a statement regarding vaccine availability in the country and ramping up its production. SII issued Poonawalla's statement after some of his comments on vaccine production were misinterpreted.

• 

  Covishield production in full swing in Pune, will return to India soon, says Adar Poonawalla

  India | May 02, 2021 9:37 IST

  Serum Institute of India CEO Aadar Poonawalla has said that the production of COVID-19 vaccine Covishield is in full swing in Pune and he will review the operations once he is back in the country.

• 

  Mumbai Police sends back some beneficiaries from BKC jumbo vaccination centre.

  News | May 01, 2021 11:00 IST

  Mumbai Police today send back some beneficiaries from BKC jumbo COVID19 vaccination centre. A beneficiary says, 'Nobody has come here yet. We're being told we won't get vaccines.' Another beneficiary Akshat says, 'I was given a timing for afternoon but I reached early.'

• 

  9 AM News | Covid-19: Only six states to begin vaccination for 18+ from today

  News | May 01, 2021 10:08 IST

  Only six states—Maharashtra, Rajasthan, UP, Chhattisgarh, Gujarat and Odisha—will start vaccination for the 18 to 44 age group when the nationwide drive to inoculate the younger lot kickstart on Saturday.

• 

  Covid-19 vaccination for 18+ to begin today

  News | May 01, 2021 8:40 IST

  As the third phase of India’s Covid-19 vaccination drive begins on May 1 with all those above the age of 18 years becoming eligible, some major private hospitals announced the launch of their immunization programmes for people in the age group of 18 to 44 years at limited centres in the country on Friday.

• 

  Adar Poonawalla, Serum Institute CEO, to get 'Y' category security

  India | April 28, 2021 20:05 IST

  According to the Home ministry's order, Poonawalla will be provided security by the Central Reserve Police Force (CRPF) wherever he travels in India.

• 

  Maharashtra govt writes to SII, Bharat Biotech about their demand of COVID-19 vaccines

  India | April 28, 2021 11:16 IST

  Maharashtra remains one of the worst-COVID-affected states in the country. As many as 66,358 new cases, 895 deaths and 67,752 recoveries were reported on Tuesday. The total case tally stands at 44,100,85.

Advertisement
• 

  Reduce vaccine price: Govt tells Serum Institute, Bharat Biotech

  India | April 26, 2021 20:16 IST

  The move has come days ahead of India's planned drive to inoculate all aged above 18. The vaccination drive is set to begin May 1.

• 

  Private hospitals to get limited portion of Covishield at Rs 600 per dose: SII

  India | April 24, 2021 19:12 IST

  The Serum Institute of India (SII) on Saturday said only a limited portion of its vaccines volume will be sold to private hospitals at Rs 600 per dose.

• 

  BJP MLA slams SII over anti-COVID vaccine pricing, calls its CEO Adar Poonawalla 'dacoit'

  India | April 22, 2021 16:55 IST

  Gorakhpur MLA Dr Radha Mohan Das Agrawal made the remarks after SII on Wednesday announced a price of Rs 600 per dose for Covishield supplies to private hospitals and Rs 400 per dose to state govts.

• 

  Sonu Sood, Farhan Akhtar question SII for disparity in 'Covishield' prices between Centre, states

  Celebrities | April 21, 2021 21:17 IST

  Bollywood actors Farhan Akhtar and Sonu Sood questioned why Serum Institute was not providing its Covishield vaccine at the same price to the centre and the states. 

• 

  SII CEO Poonawalla lauds PM Modi, Sitharaman for boost to vaccine production

  News | April 21, 2021 8:40 IST

  Serum Institute of India (SII) CEO Adar Poonawalla on Tuesday lauded Prime Minister Narendra Modi and Union finance minister Nirmala Sitharaman for what he called a ‘decisive policy changes’ and ‘swift financial aid’ to help Covid-19 vaccine production and distribution in India.

• 

  Scale up production, will provide all help: PM Modi tells vaccine manufacturers

  India | April 21, 2021 0:11 IST

  The Drugs Controller General of India (DCGI) had in January given the emergency use authorisation for two COVID-19 vaccines -- Covaxin of Bharat Biotech and Covishield of Oxford-AstraZeneca manufactured by Serum Institute of India in Pune.

• 

  'Understand India's pharmaceutical needs': US to consider lifting ban on vaccine raw material supply

  World | April 20, 2021 14:50 IST

  The Biden administration has conveyed to India that they understand India's pharmaceutical requirements and has promised to review embargo on Covid-19 vaccine raw material.

• 

  Govt to provide Rs 4,500 cr booster to SII, Bharat Biotech for ramping up Covid vaccine production

  India | April 20, 2021 12:30 IST

  COVID-19 vaccine: SII will supply 200 million doses and Bharat Biotech is to supply another 90 million doses to the government by July at a pre-agreed rate of Rs 150 per dose.  

• 

  WHO rejects Serum Institute's proposal seeking extension of Covishield's shelf life to 9 months

  World | April 08, 2021 20:03 IST

  ​The WHO has rejected Serum Institute of India's proposal seeking extension of the shelf life of Oxford-AstraZeneca COVID-19 vaccine, Covishield, from six to nine months, citing insufficient data, sources said.